Contact
searchSearch
HMP Global

Hair and Trichology

Featured

Alopecia
News
Upadacitinib Shows Consistent Efficacy Across Alopecia Areata Subgroups, Including Pediatric and JAK-Refractory Patients
03/31/2026
Riya Gandhi, MA
Meta-analysis reveals robust SALT improvements regardless of age, dose, or prior JAK inhibitor exposure.
Meta-analysis reveals robust SALT improvements regardless of age, dose, or prior JAK inhibitor exposure.
Meta-analysis reveals robust...
03/31/2026
The Dermatologist
oral medicine
News
Oral Supplementation Enhances Hair Strength and Collagen VII Expression in Patients With Hair Loss
03/31/2026
Riya Gandhi, MA
Combined nutraceutical formulation shows measurable improvements in hair resistance and structural biomarkers over 90 days.
Combined nutraceutical formulation shows measurable improvements in hair resistance and structural biomarkers over 90 days.
Combined nutraceutical...
03/31/2026
The Dermatologist
News
Upadacitinib Shows Promising Efficacy in Pediatric Refractory Alopecia Areata With Favorable Safety Profile
03/30/2026
Riya Gandhi, MA
Retrospective data suggest meaningful hair regrowth and tolerability in children with severe, treatment-resistant alopecia areata.
Retrospective data suggest meaningful hair regrowth and tolerability in children with severe, treatment-resistant alopecia areata.
Retrospective data suggest...
03/30/2026
The Dermatologist
alopecia areata
News
Upadacitinib Drives Robust Hair Regrowth in Adolescents and Adults With Severe Alopecia Areata
03/30/2026
Riya Gandhi, MA
Phase 3 subgroup analysis shows significant scalp and facial hair regrowth with upadacitinib, with consistent safety across age groups.
Phase 3 subgroup analysis shows significant scalp and facial hair regrowth with upadacitinib, with consistent safety across age groups.
Phase 3 subgroup analysis shows...
03/30/2026
The Dermatologist
alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
Impact of the Gut and Skin Microbiome in Alopecia
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
Treatment Preferences of Adults and Adolescents With Alopecia Areata
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
Reflectance Confocal Microscopy and Dermoscopy: Insights Into Linear Alopecia in Pediatric Patients
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
Possible Association Between Genetically Predicted Rheumatoid Arthritis and Alopecia Areata
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
Clinical Benefits of Baricitinib Therapy in Patients With Severe Alopecia Areata
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist

Expert Insights

Dr Natasha Atanaskova Mesinkovska
Podcasts
Dr Natasha Atanaskova Mesinkovska on Alopecia Areata
05/16/2023
Natasha Atanaskova Mesinkovska, MD, PhD
In this exclusive interview, Dr Natasha Atanaskova Mesinkovska discussed her session on hair loss and treatment options for alopecia areata.
In this exclusive interview, Dr Natasha Atanaskova Mesinkovska discussed her session on hair loss and treatment options for alopecia areata.
In this exclusive interview, Dr...
05/16/2023
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Feature Story
Growing in Your Hair Practice
02/16/2021
Lauren Mateja
With the emphasis on emergent conditions and chronic disease management, dermatology sometimes overlooks the importance of hair. Patients who have seen a dermatologist may exhibit signs and symptoms of alopecia,...
With the emphasis on emergent conditions and chronic disease management, dermatology sometimes overlooks the importance of hair. Patients who have seen a dermatologist may exhibit signs and symptoms of alopecia,...
With...
02/16/2021
The Dermatologist
Feature Story
Treating Androgenetic Alopecia: A Review of Nonsurgical Options
07/15/2020
Androgenetic alopecia (AGA) is a common form of hair loss that affects an estimated 80 million Americans.1 In men, it can begin as early as the teen years and follows a characteristic pattern, and in women, AGA...
Androgenetic alopecia (AGA) is a common form of hair loss that affects an estimated 80 million Americans.1 In men, it can begin as early as the teen years and follows a characteristic pattern, and in women, AGA...
...
07/15/2020
The Dermatologist
Feature Story
Hair Loss Treatments: A Word of Caution
09/04/2008
More than 50% of the population of men in their 50s has cosmetically significant male pattern hair loss. No doubt, the pressure on individuals to look younger comes from all directions in our society.
More than 50% of the population of men in their 50s has cosmetically significant male pattern hair loss. No doubt, the pressure on individuals to look younger comes from all directions in our society.
More than 50% of the population...
09/04/2008
The Dermatologist
Goldberg
Videos
Image-Guided SRT for Nonmelanoma Skin Cancer
10/16/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how high-resolution ultrasound guidance is improving superficial radiation therapy for nonmelanoma skin cancers.
Dr David Goldberg discusses how...
10/16/2026
The Dermatologist
Dr Martina Porter
Videos
Expert Insights: Povorcitinib for Hidradenitis Suppurativa
10/15/2026
Martina Porter, MD; Jessica Garlewicz
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50 responses in moderate-to-severe hidradenitis suppurativa, with higher dosing potentially benefiting patients with more severe disease and a generally favorable safety profile through 54 weeks.
Povorcitinib improved HiSCR50...
10/15/2026
The Dermatologist
Dr Lisa Swanson
Videos
Biologic Decision-Making for Moderate-to-Severe Atopic Dermatitis
10/15/2026
Jessica Garlewicz; Elizabeth Swanson, MD
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of moderate-to-severe atopic dermatitis should consider overall disease burden, patient-specific factors and preferences, and clear treatment expectations to guide systemic therapy selection and support adherence.
Individualized management of...
10/15/2026
The Dermatologist
Dr Raj Chovatiya
Videos
Optimizing Biologic Treatment Decisions in Moderate-to-Severe Atopic Dermatitis
10/15/2026
Raj Chovatiya, MD, PhD; Jessica Garlewicz
Raj Chovatiya, MD, PhD, emphasizes individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD, emphasizes individualized biologic selection, shared decision-making, and adequate treatment optimization before switching therapies in patients with moderate-to-severe atopic dermatitis.
Raj Chovatiya, MD, PhD,...
10/15/2026
The Dermatologist
Cover Story
The Industry Dermatologist: Building a Career at the Intersection of Science, Innovation, and Patient Care
10/02/2026
Ayman Grada, MD, MHA; Riya Gandhi, MA
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his...
10/02/2026
The Dermatologist
cohen
Videos
Targeting Type 2 Inflammation in Eczema, Prurigo Nodularis, and Urticaria
10/01/2026
Jeffrey M. Cohen, MD; Riya Gandhi, MA
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how IL-4, IL-13, and IL-31 drive inflammation and itch across eczema, prurigo nodularis, and chronic urticaria.
Dr Jeffrey Cohen discusses how...
10/01/2026
The Dermatologist
Goldberg
Videos
Prolactin Receptor Inhibition for Hair Loss: A New Frontier in Hair Regrowth
09/28/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses emerging prolactin receptor–targeted therapies for androgenetic alopecia and other hair disorders.
Dr David Goldberg discusses...
09/28/2026
The Dermatologist
Bloom
Videos
Biostimulatory Fillers in Facial Rejuvenation
09/28/2026
Jason Bloom, MD, FACS; Riya Gandhi, MA
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the evolution of facial rejuvenation from line-filling to comprehensive facial balancing through volumization and biostimulation.
Dr Jason Bloom discusses the...
09/28/2026
The Dermatologist
Doris Day
Videos
Facial Fillers: Holistic Rejuvenation, Facial Balancing, and Natural Results
09/28/2026
Doris Day, MD; Riya Gandhi, MA
Dr Doris Day discusses why facial fillers continue to grow in popularity by shifting beyond simple volumization toward holistic facial balancing and longevity-focused rejuvenation.
Dr Doris Day discusses why facial fillers continue to grow in popularity by shifting beyond simple volumization toward holistic facial balancing and longevity-focused rejuvenation.
Dr Doris Day discusses why...
09/28/2026
The Dermatologist
Helen He
Videos
Inflammaging and Cellular Senescence: Emerging Strategies for Skin Longevity
09/28/2026
Helen He, MD; Riya Gandhi, MA
Dr Helen He discusses how cellular senescence and inflammaging work together to accelerate intrinsic and extrinsic skin aging.
Dr Helen He discusses how cellular senescence and inflammaging work together to accelerate intrinsic and extrinsic skin aging.
Dr Helen He discusses how...
09/28/2026
The Dermatologist

News

alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
Impact of the Gut and Skin Microbiome in Alopecia
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
Treatment Preferences of Adults and Adolescents With Alopecia Areata
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
Reflectance Confocal Microscopy and Dermoscopy: Insights Into Linear Alopecia in Pediatric Patients
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
Possible Association Between Genetically Predicted Rheumatoid Arthritis and Alopecia Areata
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
Clinical Benefits of Baricitinib Therapy in Patients With Severe Alopecia Areata
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist
alopecia areata
News
Utilizing Autologous Adipose Tissue Injection in Alopecia Treatment
11/17/2023
Jessica Garlewicz
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the...
11/17/2023
The Dermatologist
alopecia areata
News
Association Between Zinc Deficiency and Alopecia Areata
11/16/2023
Jessica Garlewicz
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for...
11/16/2023
The Dermatologist
alopecia areata
News
Links Between Alopecia Areata and Auditory Dysfunction
10/23/2023
Jessica Garlewicz
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate...
10/23/2023
The Dermatologist
cream
News
Behenic Acid and Ceramide Creams Accelerate Skin Barrier Recovery
10/13/2026
Coleen Stern, MA
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid...
10/13/2026
The Dermatologist
FDA Alerts
FDA Approves Rhapsido as First Treatment for Symptomatic Dermographism in Adults
10/08/2026
Jessica Garlewicz
On October 7, 2026, the US Food and Drug Administration approved remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, as the first treatment for adults with symptomatic dermographism inadequately controlled by H1...
On October 7, 2026, the US Food and Drug Administration approved remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, as the first treatment for adults with symptomatic dermographism inadequately controlled by H1...
On October 7, 2026, the US Food...
10/08/2026
The Dermatologist
News
GLP-1 Receptor Agonists Linked to Lower Mortality, Cardiovascular Risk in Patients With Psoriasis
10/07/2026
Jessica Garlewicz
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor...
10/07/2026
The Dermatologist
Smiling woman touching neck
News
Anatomy-Driven Model Aims to Prevent GLP-1 RA–Associated Facial Aging
10/01/2026
Coleen Stern, MA
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an...
10/01/2026
The Dermatologist
dkin
News
Review Reframes Skin Barrier as an Integrated Defense System
09/30/2026
Coleen Stern, MA
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an...
09/30/2026
The Dermatologist
Alopecia
FDA Alerts
FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata
09/28/2026
Riya Gandhi, MA
FDA has expanded the indication for baricitinib (Olumiant) to include adolescents aged 12 years and older with severe alopecia areata, based on results from the Phase 3 BRAVE-AA-PEDS trial.
FDA has expanded the indication for baricitinib (Olumiant) to include adolescents aged 12 years and older with severe alopecia areata, based on results from the Phase 3 BRAVE-AA-PEDS trial.
FDA has expanded the indication...
09/28/2026
The Dermatologist
News
Global Psoriasis Burden Nearly Doubled Over 3 Decades, Economic Costs Reach $149 Billion
09/03/2026
Jessica Garlewicz
Investigators assessed trends in psoriasis cases, effects on quality of life, and associated economic costs.
Investigators assessed trends in psoriasis cases, effects on quality of life, and associated economic costs.
Investigators assessed trends in...
09/03/2026
The Dermatologist
FDA Alerts
FDA Approves Lisraya as First Oral Therapy for Adult Dermatomyositis
08/31/2026
Coleen Stern, MA
For dermatologists and patients, this approval provides a new alternative targeting the JAK-mediated inflammation that damages the muscles and skin in dermatomyositis to control both cutaneous and systemic manifestations.
For dermatologists and patients, this approval provides a new alternative targeting the JAK-mediated inflammation that damages the muscles and skin in dermatomyositis to control both cutaneous and systemic manifestations.
For dermatologists and patients,...
08/31/2026
The Dermatologist
FDA Alerts
FDA Grants Accelerated Approval to Tudriqev for PD-1-Refractory Advanced Melanoma
08/07/2026
Jessica Garlewicz
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug...
08/07/2026
The Dermatologist
roflum
FDA Alerts
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2 Years
06/30/2026
Riya Gandhi, MA
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes...
06/30/2026
The Dermatologist

Quizzes and Polls

Quiz
Trivia: Alopecia Areata
03/29/2019
Which finding is common among patients with alopecia areata affecting the nails?
Which finding is common among patients with alopecia areata affecting the nails?
Which finding is common among...
03/29/2019
The Dermatologist
AD
Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
Quiz
Quiz: Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
october 2026

Current Issue

October 2026
Volume 34
Issue 7
Current Issue
Issue Archive

Recent News

alopecia areata
News
Study Highlights Patient-Driven Risk Tolerance for Ritlecitinib in Severe Alopecia Areata
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
Impact of the Gut and Skin Microbiome in Alopecia
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
Treatment Preferences of Adults and Adolescents With Alopecia Areata
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
Reflectance Confocal Microscopy and Dermoscopy: Insights Into Linear Alopecia in Pediatric Patients
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
Possible Association Between Genetically Predicted Rheumatoid Arthritis and Alopecia Areata
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
Clinical Benefits of Baricitinib Therapy in Patients With Severe Alopecia Areata
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
Screening For Latent Infectious Disease in Patients With Alopecia Areata Before Using JAK Inhibitors
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist
alopecia areata
News
Utilizing Autologous Adipose Tissue Injection in Alopecia Treatment
11/17/2023
Jessica Garlewicz
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the...
11/17/2023
The Dermatologist
alopecia areata
News
Association Between Zinc Deficiency and Alopecia Areata
11/16/2023
Jessica Garlewicz
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for...
11/16/2023
The Dermatologist
alopecia areata
News
Links Between Alopecia Areata and Auditory Dysfunction
10/23/2023
Jessica Garlewicz
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate...
10/23/2023
The Dermatologist
cream
News
Behenic Acid and Ceramide Creams Accelerate Skin Barrier Recovery
10/13/2026
Coleen Stern, MA
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid...
10/13/2026
The Dermatologist
FDA Alerts
FDA Approves Rhapsido as First Treatment for Symptomatic Dermographism in Adults
10/08/2026
Jessica Garlewicz
On October 7, 2026, the US Food and Drug Administration approved remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, as the first treatment for adults with symptomatic dermographism inadequately controlled by H1...
On October 7, 2026, the US Food and Drug Administration approved remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, as the first treatment for adults with symptomatic dermographism inadequately controlled by H1...
On October 7, 2026, the US Food...
10/08/2026
The Dermatologist
News
GLP-1 Receptor Agonists Linked to Lower Mortality, Cardiovascular Risk in Patients With Psoriasis
10/07/2026
Jessica Garlewicz
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor...
10/07/2026
The Dermatologist
Smiling woman touching neck
News
Anatomy-Driven Model Aims to Prevent GLP-1 RA–Associated Facial Aging
10/01/2026
Coleen Stern, MA
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an...
10/01/2026
The Dermatologist
dkin
News
Review Reframes Skin Barrier as an Integrated Defense System
09/30/2026
Coleen Stern, MA
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an...
09/30/2026
The Dermatologist
Alopecia
FDA Alerts
FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata
09/28/2026
Riya Gandhi, MA
FDA has expanded the indication for baricitinib (Olumiant) to include adolescents aged 12 years and older with severe alopecia areata, based on results from the Phase 3 BRAVE-AA-PEDS trial.
FDA has expanded the indication for baricitinib (Olumiant) to include adolescents aged 12 years and older with severe alopecia areata, based on results from the Phase 3 BRAVE-AA-PEDS trial.
FDA has expanded the indication...
09/28/2026
The Dermatologist
News
Global Psoriasis Burden Nearly Doubled Over 3 Decades, Economic Costs Reach $149 Billion
09/03/2026
Jessica Garlewicz
Investigators assessed trends in psoriasis cases, effects on quality of life, and associated economic costs.
Investigators assessed trends in psoriasis cases, effects on quality of life, and associated economic costs.
Investigators assessed trends in...
09/03/2026
The Dermatologist
FDA Alerts
FDA Approves Lisraya as First Oral Therapy for Adult Dermatomyositis
08/31/2026
Coleen Stern, MA
For dermatologists and patients, this approval provides a new alternative targeting the JAK-mediated inflammation that damages the muscles and skin in dermatomyositis to control both cutaneous and systemic manifestations.
For dermatologists and patients, this approval provides a new alternative targeting the JAK-mediated inflammation that damages the muscles and skin in dermatomyositis to control both cutaneous and systemic manifestations.
For dermatologists and patients,...
08/31/2026
The Dermatologist
FDA Alerts
FDA Grants Accelerated Approval to Tudriqev for PD-1-Refractory Advanced Melanoma
08/07/2026
Jessica Garlewicz
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug...
08/07/2026
The Dermatologist
roflum
FDA Alerts
FDA Approves Roflumilast Cream 0.3% for Plaque Psoriasis in Children as Young as 2 Years
06/30/2026
Riya Gandhi, MA
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes roflumilast cream 0.3% the first once-daily, steroid-free topical therapy approved for plaque psoriasis in children aged 2 years and older, providing a new long-term treatment option for pediatric patients.
The expanded indication makes...
06/30/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use